MOTTA, MARIA ROSA
MOTTA, MARIA ROSA
DIPARTIMENTO DI MEDICINA SPECIALISTICA, DIAGNOSTICA E SPERIMENTALE (attivo dal 28/10/2011 al 31/12/2022)
Personale esterno ed autonomi
The timing of plerixafor addition to G-Csf and chemotherapy affects immunological recovery after autologous stem cell transplant in multiple myeloma
2020 Tolomelli, Giulia; Mancuso, Katia; Tacchetti, Paola; Patriarca, Francesca; Galli, Monica; Pantani, Lucia; Zannetti, Beatrice; Motta, Maria Rosa; Rizzi, Simonetta; Dan, Elisa; Sinigaglia, Barbara; Giudice, Valeria; Olmo, Andrea; Arpinati, Mario; Chirumbolo, Gabriella; Fanin, Renato; Lewis, Russell E; Paris, Laura; Bonifazi, Francesca; Cavo, Michele; Curti, Antonio; Lemoli, Roberto M
The timing of plerixafor addition to G-Csf and chemotherapy affects immunological recovery after autologous stem cell transplant in multiple myeloma
2020 Tolomelli G.; Mancuso K.; Tacchetti P.; Patriarca F.; Galli M.; Pantani L.; Zannetti B.; Motta M.R.; Rizzi S.; Dan E.; Sinigaglia B.; Giudice V.; Olmo A.; Arpinati M.; Chirumbolo G.; Fanin R.; Lewis R.E.; Paris L.; Bonifazi F.; Cavo M.; Curti A.; Lemoli R.M.
Intrabone transplant provides full stemness of cord blood stem cells with fast hematopoietic recovery and low GVHD rate: results from a prospective study
2019 Bonifazi, Francesca; Dan, Elisa; Labopin, Myriam; Sessa, Mariarosaria; Guadagnuolo, Viviana; Ferioli, Martina; Rizzi, Simonetta; De Carolis, Sabrina; Sinigaglia, Barbara; Motta, Maria Rosa; Bontadini, Andrea; Giudice, Valeria; Martinelli, Giovanni; Arpinati, Mario; Cavo, Michele; Bonafé, Massimiliano; Storci, Gianluca
Low-Dose Anti-T Lymphoglobulin as Prophylaxis for Graft-versus-Host Disease in Unrelated Donor Transplantations for Acute Leukemias and Myelodysplastic Syndromes.
2018 Bonifazi F, Olivieri J, Sessa M, Dan E, Sinigaglia B, Rizzi S, Motta MR, Bontadini A, Ulbar F, Giudice V, Papayannidis C, Curti A, Chiereghin A, Lazzarotto T, Cavo M, Arpinati M.
Larger size of donor alloreactive NK cell repertoire correlates with better response to NK cell immunotherapy in elderly acute myeloid leukemia patients
2016 Curti, Antonio; Ruggeri, Loredana; Parisi, Sarah; Bontadini, Andrea; Dan, Elisa; Motta, MARIA ROSA; Rizzi, Simonetta; Trabanelli, Sara; Ocadlikova, Darina; Lecciso, MARIANGELA STEFANIA; Giudice, Valeria; Fruet, Fiorenza; Urbani, Elena; Papayannidis, Cristina; Martinelli, Giovanni; Bandini, Giuseppe; Bonifazi, Francesca; Lewis, RUSSEL EDWARD; Cavo, Michele; Velardi, Andrea; M. Lemoli, Roberto
Donor Natural Killer (NK) Alloreactivity Predicts Long-Term Relapse-Free Survival in Acute Myeloid Leukemia Patients Undergoing Immunotherapy with NK Cells
2014 Antonio Curti, Loredana Ruggeri, Sarah Parisi, Andrea Bontadini, Elisa Dan, Simonetta Rizzi, Maria Rosa Motta, Sara Trabanelli, Darina Ocadlikova, Mariangela Lecciso, Valeria Giudice, Elena Urbani, Cristina Papayannidis, Giovanni Martinelli, Francesca Bonifazi, Giuseppe Bandini, Fiorenza Fruet, Russel E. Lewis, Michele Cavo, Andrea Velardi, Roberto M. Lemoli
Glutathione transferase-A2 S112T polymorphism predicts survival, transplant-related mortality, busulfan and bilirubin blood levels after allogeneic stem cell transplantation
2014 F. Bonifazi;G. Storci;G. Bandini;E. Marasco;E. Dan;E. Zani;F. Albani;S. Bertoni;A. Bontadini;S. De Carolis;M. R. Sapienza;S Rizzi;M. R. Motta;M. Ferioli;P. Garagnani;M. Cavo;V. Mantovani;M. Bonafe
Hairy Cell Leukemia: Allogeneic Transplantation Could be an Optimal Option in Selected Patients.
2012 Zinzani PL; Bonifazi F; Pellegrini C; Casadei B; Argnani L; Motta MR; Dan E; Stanzani M; Arpinati M; Bandini G.
Intensification of GVHD prophylaxis with low-dose ATG-F before allogeneic PBSC transplantation from HLA-identical siblings in adult patients with hematological malignancies: results from a retrospective analysis
2012 F. Bonifazi; G. Bandini; M. Arpinati; G. Tolomelli; M. Stanzani; M. R. Motta; S. Rizzi; V. Giudice; E. Dan; E. Massari; P. Tazzari; A. Bontadini; P. Pagliaro; M. Baccarani
Successful transfer of alloreactive haploidentical KIR ligand-mismatched natural killer cells after infusion in elderly high risk acute myeloid leukemia patients.
2011 Curti A.; Ruggeri L.; D'Addio A.; Bontadini A.; Dan E.; Motta M.R.; Trabanelli S.; Giudice V.; Urbani E.; Martinelli G.; Paolini S.; Fruet F.; Isidori A.; Parisi S.; Bandini G.; Baccarani M.; Velardi A.; Lemoli R.M.
The addition of plerixafor is safe and allows adequate PBSC collection in multiple myeloma and lymphoma patients poor mobilizers after chemotherapy and G-CSF.
2011 D'Addio A; Curti A; Worel N; Douglas K; Motta MR; Rizzi S; Dan E; Taioli S; Giudice V; Agis H; Kopetzky G; Soutar R; Casadei B; Baccarani M; Lemoli R.M.
Erratum: Phase II study of a single pegfilgrastim injection as an adjunct to chemotherapy to mobilize stem cells into the peripheral blood of pretreated lymphoma patients (Haematologica (2005) 90, (225-231).
2007 Isidori A.; Tani M.; Bonifazi F.; Zinzani P.; Curti A.; Motta M.R.; Rizzi S.; Giudice V.; Farese O.; Rovito M.; Alinari L.; Conte R.; Baccarani M.; Lemoli R.M.
Molecular and cytogenetic characterization of a new case of t(5;17)(q35;q21) variant acute promyelocytic leukemia
2005 NICCI C; OTTAVIANI E; LUATTI S; GRAFONE T; TONELLI M; MOTTA MR; MALAGOLA M; MARZOCCHI G; MARTINELLI G; BACCARANI M; TESTONI N.
Phase II study of a single pegfilgrastim injection as an adjunct to chemotherapy to mobilize stem cells into the peripheral blood of pretreated lymphoma patients.
2005 ISIDORI A; TANI M; BONIFAZI F; ZINZANI P; CURTI A; MOTTA MR; RIZZI S; GIUDICE V; FARESE O; ROVITO M; ALINARI L; CONTE R; BACCARANI M.; LEMOLI RM.
High-dose therapy with autologous transplantation for aggressive non-Hodgkin's lymphoma: the Bologna experience
2004 ZINZANI P.L.; TANI M.; GABRIELE A.; GHERLINZONI F.; DE VIVO A.; RICCI P.; BANDINI G.; LEMOLI R.M.; MOTTA M.R.; RIZZI S.; GUIDICE V.; ZOMPATORI M.; STEFONI V.; ALINARI L.; MUSURACA G.; MARCHI E.; BASSI S.; CONTE R.; PILERI S.; TURA S.; BACCARANI M.
Critical analysis of the radioimmunological methods of determining creatine kinase isoenzyme MB (CK-MB), myoglobin (MG) and of LDH (H4) in ischemic cardiopathy
1980 Martinelli M.; Bugiardini R.; Vinelli S.; Puddu P.; Bugiardini G.; Capelli M.; Cocchi V.; Motta R.
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| The timing of plerixafor addition to G-Csf and chemotherapy affects immunological recovery after autologous stem cell transplant in multiple myeloma | Tolomelli, Giulia; Mancuso, Katia; Tacchetti, Paola; Patriarca, Francesca; Galli, Monica; Pantani..., Lucia; Zannetti, Beatrice; Motta, Maria Rosa; Rizzi, Simonetta; Dan, Elisa; Sinigaglia, Barbara; Giudice, Valeria; Olmo, Andrea; Arpinati, Mario; Chirumbolo, Gabriella; Fanin, Renato; Lewis, Russell E; Paris, Laura; Bonifazi, Francesca; Cavo, Michele; Curti, Antonio; Lemoli, Roberto M | 2020-01-01 | BONE MARROW TRANSPLANTATION | - | 1.01 Articolo in rivista | - |
| The timing of plerixafor addition to G-Csf and chemotherapy affects immunological recovery after autologous stem cell transplant in multiple myeloma | Tolomelli G.; Mancuso K.; Tacchetti P.; Patriarca F.; Galli M.; Pantani L.; Zannetti B.; Motta M....R.; Rizzi S.; Dan E.; Sinigaglia B.; Giudice V.; Olmo A.; Arpinati M.; Chirumbolo G.; Fanin R.; Lewis R.E.; Paris L.; Bonifazi F.; Cavo M.; Curti A.; Lemoli R.M. | 2020-01-01 | BONE MARROW TRANSPLANTATION | - | 1.01 Articolo in rivista | - |
| Intrabone transplant provides full stemness of cord blood stem cells with fast hematopoietic recovery and low GVHD rate: results from a prospective study | Bonifazi, Francesca; Dan, Elisa; Labopin, Myriam; Sessa, Mariarosaria; Guadagnuolo, Viviana; Feri...oli, Martina; Rizzi, Simonetta; De Carolis, Sabrina; Sinigaglia, Barbara; Motta, Maria Rosa; Bontadini, Andrea; Giudice, Valeria; Martinelli, Giovanni; Arpinati, Mario; Cavo, Michele; Bonafé, Massimiliano; Storci, Gianluca | 2019-01-01 | BONE MARROW TRANSPLANTATION | - | 1.01 Articolo in rivista | s41409-018-0335-x.pdf |
| Low-Dose Anti-T Lymphoglobulin as Prophylaxis for Graft-versus-Host Disease in Unrelated Donor Transplantations for Acute Leukemias and Myelodysplastic Syndromes. | Bonifazi F, Olivieri J, Sessa M, Dan E, Sinigaglia B, Rizzi S, Motta MR, Bontadini A, Ulbar F, Gi...udice V, Papayannidis C, Curti A, Chiereghin A, Lazzarotto T, Cavo M, Arpinati M. | 2018-01-01 | BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | - | 1.01 Articolo in rivista | - |
| Larger size of donor alloreactive NK cell repertoire correlates with better response to NK cell immunotherapy in elderly acute myeloid leukemia patients | Curti, Antonio; Ruggeri, Loredana; Parisi, Sarah; Bontadini, Andrea; Dan, Elisa; Motta, MARIA ROS...A; Rizzi, Simonetta; Trabanelli, Sara; Ocadlikova, Darina; Lecciso, MARIANGELA STEFANIA; Giudice, Valeria; Fruet, Fiorenza; Urbani, Elena; Papayannidis, Cristina; Martinelli, Giovanni; Bandini, Giuseppe; Bonifazi, Francesca; Lewis, RUSSEL EDWARD; Cavo, Michele; Velardi, Andrea; M. Lemoli, Roberto | 2016-01-01 | CLINICAL CANCER RESEARCH | - | 1.01 Articolo in rivista | - |
| Donor Natural Killer (NK) Alloreactivity Predicts Long-Term Relapse-Free Survival in Acute Myeloid Leukemia Patients Undergoing Immunotherapy with NK Cells | Antonio Curti, Loredana Ruggeri, Sarah Parisi, Andrea Bontadini, Elisa Dan, Simonetta Rizzi, Mari...a Rosa Motta, Sara Trabanelli, Darina Ocadlikova, Mariangela Lecciso, Valeria Giudice, Elena Urbani, Cristina Papayannidis, Giovanni Martinelli, Francesca Bonifazi, Giuseppe Bandini, Fiorenza Fruet, Russel E. Lewis, Michele Cavo, Andrea Velardi, Roberto M. Lemoli | 2014-01-01 | BLOOD | - | 1.06 Abstract in rivista | - |
| Glutathione transferase-A2 S112T polymorphism predicts survival, transplant-related mortality, busulfan and bilirubin blood levels after allogeneic stem cell transplantation | F. Bonifazi;G. Storci;G. Bandini;E. Marasco;E. Dan;E. Zani;F. Albani;S. Bertoni;A. Bontadini;S. D...e Carolis;M. R. Sapienza;S Rizzi;M. R. Motta;M. Ferioli;P. Garagnani;M. Cavo;V. Mantovani;M. Bonafe | 2014-01-01 | HAEMATOLOGICA | - | 1.01 Articolo in rivista | haematologica.pdf |
| Hairy Cell Leukemia: Allogeneic Transplantation Could be an Optimal Option in Selected Patients. | Zinzani PL; Bonifazi F; Pellegrini C; Casadei B; Argnani L; Motta MR; Dan E; Stanzani M; Arpinati... M; Bandini G. | 2012-01-01 | CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | - | 1.01 Articolo in rivista | - |
| Intensification of GVHD prophylaxis with low-dose ATG-F before allogeneic PBSC transplantation from HLA-identical siblings in adult patients with hematological malignancies: results from a retrospective analysis | F. Bonifazi; G. Bandini; M. Arpinati; G. Tolomelli; M. Stanzani; M. R. Motta; S. Rizzi; V. Giudic...e; E. Dan; E. Massari; P. Tazzari; A. Bontadini; P. Pagliaro; M. Baccarani | 2012-01-01 | BONE MARROW TRANSPLANTATION | - | 1.01 Articolo in rivista | - |
| Successful transfer of alloreactive haploidentical KIR ligand-mismatched natural killer cells after infusion in elderly high risk acute myeloid leukemia patients. | Curti A.; Ruggeri L.; D'Addio A.; Bontadini A.; Dan E.; Motta M.R.; Trabanelli S.; Giudice V.; Ur...bani E.; Martinelli G.; Paolini S.; Fruet F.; Isidori A.; Parisi S.; Bandini G.; Baccarani M.; Velardi A.; Lemoli R.M. | 2011-01-01 | BLOOD | - | 1.01 Articolo in rivista | - |
| The addition of plerixafor is safe and allows adequate PBSC collection in multiple myeloma and lymphoma patients poor mobilizers after chemotherapy and G-CSF. | D'Addio A; Curti A; Worel N; Douglas K; Motta MR; Rizzi S; Dan E; Taioli S; Giudice V; Agis H; Ko...petzky G; Soutar R; Casadei B; Baccarani M; Lemoli R.M. | 2011-01-01 | BONE MARROW TRANSPLANTATION | - | 1.01 Articolo in rivista | - |
| Erratum: Phase II study of a single pegfilgrastim injection as an adjunct to chemotherapy to mobilize stem cells into the peripheral blood of pretreated lymphoma patients (Haematologica (2005) 90, (225-231). | Isidori A.; Tani M.; Bonifazi F.; Zinzani P.; Curti A.; Motta M.R.; Rizzi S.; Giudice V.; Farese ...O.; Rovito M.; Alinari L.; Conte R.; Baccarani M.; Lemoli R.M. | 2007-01-01 | HAEMATOLOGICA | - | 1.01 Articolo in rivista | - |
| Molecular and cytogenetic characterization of a new case of t(5;17)(q35;q21) variant acute promyelocytic leukemia | NICCI C; OTTAVIANI E; LUATTI S; GRAFONE T; TONELLI M; MOTTA MR; MALAGOLA M; MARZOCCHI G; MARTINEL...LI G; BACCARANI M; TESTONI N. | 2005-01-01 | LEUKEMIA | - | 1.01 Articolo in rivista | - |
| Phase II study of a single pegfilgrastim injection as an adjunct to chemotherapy to mobilize stem cells into the peripheral blood of pretreated lymphoma patients. | ISIDORI A; TANI M; BONIFAZI F; ZINZANI P; CURTI A; MOTTA MR; RIZZI S; GIUDICE V; FARESE O; ROVITO... M; ALINARI L; CONTE R; BACCARANI M.; LEMOLI RM. | 2005-01-01 | HAEMATOLOGICA | - | 1.01 Articolo in rivista | - |
| High-dose therapy with autologous transplantation for aggressive non-Hodgkin's lymphoma: the Bologna experience | ZINZANI P.L.; TANI M.; GABRIELE A.; GHERLINZONI F.; DE VIVO A.; RICCI P.; BANDINI G.; LEMOLI R.M....; MOTTA M.R.; RIZZI S.; GUIDICE V.; ZOMPATORI M.; STEFONI V.; ALINARI L.; MUSURACA G.; MARCHI E.; BASSI S.; CONTE R.; PILERI S.; TURA S.; BACCARANI M. | 2004-01-01 | LEUKEMIA & LYMPHOMA | - | 1.01 Articolo in rivista | - |
| Critical analysis of the radioimmunological methods of determining creatine kinase isoenzyme MB (CK-MB), myoglobin (MG) and of LDH (H4) in ischemic cardiopathy | Martinelli M.; Bugiardini R.; Vinelli S.; Puddu P.; Bugiardini G.; Capelli M.; Cocchi V.; Motta R. | 1980-01-01 | QUADERNI SCLAVO DI DIAGNOSTICA CLINICA E DI LABORATORIO | - | 1.01 Articolo in rivista | - |